PFE has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Pfizer Inc's quarterly cash and cash equivalents increased from Sep. 2013 ($2,052 Mil) to Dec. 2013 ($2,183 Mil) and increased from Dec. 2013 ($2,183 Mil) to Mar. 2014 ($2,862 Mil).
Pfizer Inc's annual cash and cash equivalents increased from Dec. 2011 ($3,182 Mil) to Dec. 2012 ($10,081 Mil) but then declined from Dec. 2012 ($10,081 Mil) to Dec. 2013 ($2,183 Mil).
Cash and cash equivalents on banks book.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Pfizer Inc Annual Data
Pfizer Inc Quarterly Data